SCHEMBL7146582

SCHEMBL7146582

COc1cc2c(cc1-c1ccccc1F)NC(=O)CC(c1cccc(-n3cnnc3)c1)=N2

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.64
GRM2 Q14416 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139904 0.90 CYP3A4 (0.80) CYP3A4GRM2
SCHEMBL7139988 0.84 CYP3A4 (0.58) CYP3A4GRM2
SCHEMBL5869173 0.84 CYP3A4 (0.80) CYP3A4GRM2
SCHEMBL7138915 0.82
SCHEMBL6165474 0.79 CYP3A4 (0.76) CYP3A4GRM2
SCHEMBL7142053 0.79 GRM2 (0.85) CYP3A4GRM2
SCHEMBL7147013 0.79 CYP3A4 (0.64) CYP3A4GRM2
SCHEMBL7147291 0.78 CYP3A4 (1.00) CYP3A4GRM2
SCHEMBL7145421 0.78 GRM2 (0.73) CYP3A4GRM2
SCHEMBL7139866 0.78 GRM2 (0.56) CYP3A4GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed